Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.
Frontotemporal dementia (FTD) is a common neurogenerative disorder characterized by neurodegeneration in the frontal and temporal lobes. Heterozygous mutations in the gene encoding progranulin (PGRN) are a common genetic cause of FTD. Recently PGRN has emerged as an important regulator of lysosomal function. Here, we examined the impact of PGRN mutations on the processing of full-length prosaposin to individual saposins, which are critical regulators of sphingolipid metabolism. Using FTD-PGRN patient-derived cortical neurons differentiated from induced pluripotent stem cells (iPSCs), as well as post-mortem tissue from patients with FTLD-PGRN, we show that PGRN haploinsufficiency results in impaired processing of prosaposin to saposin C, a critical activator of the lysosomal enzyme glucocerebrosidase (GCase). Additionally, we found that PGRN mutant neurons had reduced lysosomal glucocerebrosidase (GCase) activity, lipid accumulation and increased insoluble α- synuclein relative to isogenic controls. Importantly, this effect on GCase activity was rescued by treatment with saposin C. Together, these findings suggested that reduced GCase activity due to impaired processing of prosaposin may contribute to pathogenesis of FTD resulting from PGRN mutations.